A study in the August Journal of Drugs in Dermatology addressed the burden of melasma – the populations most prone to melasma and the comorbidities associated with it. According to the study’s authors, a deeper understanding of the associations of race, ethnicity and comorbidities can help dermatologists determine which patients are at risk of developing melasma and as well as potential new pa … 
Dermatologic procedures in children can be stressful for the patient, parent and the clinician. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Watch as Dr. Kirkorian shares four hot tips for procedures in kids. Find out why you might want to reconsider some … 
This July, the Journal of Drugs in Dermatology (JDD) is proud to present a special edition focused on "Bridging the Gap in Dermatology." Our Editor's Picks this month highlight groundbreaking research and discussions aimed at promoting inclusivity, representation, and innovation in dermatologic care. From advancements in sun protection to the role of social media in healthcare, these pieces provid … 
Alopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment options exist; however, there is minimal evidence in the pediatric population. Currently, there are no curative treatments for AA. The literature suggests that Janus kinase (JAK) inhibitors may be an effective t … 